Clinical Trials Directory

Trials / Completed

CompletedNCT03561519

FMT in the Treatment of IBS

FECAL MICROBIOTA TRANSPLANTATION IN THE TREATMENT OF IRRITABLE BOWEL SYNDROME

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
52 (actual)
Sponsor
Joint Authority for Päijät-Häme Social and Health Care · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

52 adult IBS patients were recruited. 50% were given a fecal microbiota transplantation in colonoscopy and 50% were given an FMT made of their own feces as placebo. follow up time was 1 year after FMT.

Detailed description

52 adult IBS patients of any subgroup(IBS-D, IBS-C or IBS-M), were recruited and given an FMT in colonoscopy. Neither the patient nor the care taking personnel did know in which group the patients belonged to. The patients were screened with fecal samples for 16RNA sequencing and they were repeatedly done IBS-SSS questionnaire and questionnaires for quality of life and psychical condition. Follow up time was 1 year after the colonoscopy.

Conditions

Interventions

TypeNameDescription
OTHERFecal Microbiota Transplantation (FMT)Fecal suspension administered in colonoscopy into the cecum of the patient.
OTHERPlaceboAs a placebo a fecal suspension made of patients own feces is administered into the cecum of the patient in colonoscopy.

Timeline

Start date
2015-08-27
Primary completion
2018-07-01
Completion
2018-07-01
First posted
2018-06-19
Last updated
2018-08-15

Locations

1 site across 1 country: Finland

Source: ClinicalTrials.gov record NCT03561519. Inclusion in this directory is not an endorsement.